FindTrial
Sign In

A study on efficacy of Saindhavadi Bidalaka in the management of Vataj Abhishyanda with special reference to allergic conjunctivitis

A single arm clinical study to evaluate the efficacy of Saindhavadi Bidalaka in the management of Vataj Abhishyanda with special reference to allergic conjunctivitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081797
Enrollment
80
Registered
2025-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

DR MANJU LALCHAND YADAV
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients showing the classical sign and symptoms of allergic Conjunctivitis will be selected for the study. 2.Patients who are between the ages of 15yr&50yr will be selected for the study 3.Patients irrespective of sex, occupation and socio-economic status will be selected.

Exclusion criteria

Exclusion criteria: 1.Patients older than 50 yrs&younger than 10 yrs 2.Patients who have another eye condition 3.Patients who recently had eye surgery 4.Patients with other major systemic diseases 5.Taking any other eye medications

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Saindhavadi Bidalaka in the management of Vataj AbhishyandaTimepoint: 7 days—

Secondary

MeasureTime frame
1.To study the detail literature about Vataj Abhishyanda 2.To Study the detail literature about Allergic Conjunctivitis 3.To study the effect of Saindhavadi Bidalaka in vataj Abhishyanda with special reference to Allergic ConjunctivitisTimepoint: 7-28 days—

Countries

India

Contacts

Public ContactDR MANJU LALCHAND YADAV

LRP Ayurvedic medical college and hospital,PG institute and research centre

sunilwalvekar99@gmail.com9822442719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026